ALA 9.09% 12.0¢ arovella therapeutics limited

Ann: Notice of General Meeting/Proxy Form, page-2

  1. 362 Posts.
    lightbulb Created with Sketch. 278
    To the shareholders that automatically dismiss these AGM resolutions as not important or interesting. Consider this:

    Resolution 9 - Issuance of options to Director - Dr Michael Baker

    The issuance of 3,000,000 options. Fine, but then consider the strike prices on each tranche and ask yourself are we really incentivizing our CEO to create shareholder value?

    (c) the options will vest as follows:
    (i) 1,000,000 options will vest immediately upon their issue and will have an exerciseprice of $0.055 per option;

    (ii) 1,000,000 options will vest on the date that is 12 months following the date ofissuance of the options and will have an exercise price of $0.065 per option;

    (iii) 1,000,000 options will vest on the date that is 24 months following the date ofissuance of the options and will have an exercise price of $0.075 per option;

    Is it fair to be rewarded for a measly 7.8% share price appreciation (to $0.055) from when you joined the company. Why is such a low bar being set by the company for the free award of stock - remember this is diluting your own shareholding along the way too. I am going to guess that around 90% of the contributors on this forum have an average entry price much higher than any of the strike prices offered above.

    Then consider this - that Baker was paid a "performance bonus" for meeting certain KPI's that have not been disclosed to shareholders.

    Then this: SUD share price day Baker was appointed $0.051 (02/01/20)
    SUD share price at 30/6/20 $0.031.

    “Dr Michael Baker was granted a performance bonus of $53,625; it related to the 2020 financial year and included in the remuneration disclosure for 2020. It was paid in August 2020.”

    Baker has already been issued 2,800,000 free options by the way. Exercise prices were $0.087 for 1,200,000 / $0.093 for 800,000 / $0.099 for 800,000.

    Resolution 1 - Remuneration Report

    "The Remuneration Report is contained in the Annual Report". Thanks for the detail guys.

    I can't find anything within it that relates to KPI's for Baker and what the resultant award would be for meeting them. Are we going to get another nasty surprise in the next annual report when we've gone further backwards in terms of SP but have escalated Bakers bonus to $100k+. Remember as a contributor to the ongoing entitlement offers/cap raisings etc you are funding this bonus. You are funding a bonus paid for a share price that is going backwards.

    Resolution 8 - Approval of Employee Share Option Plan

    Why grant more long dated options to directors if there are still unexercised options still alive dating out to 2024. How about we meet the exercise prices on the first tranches issued before awarding anything further?

    https://hotcopper.com.au/data/attachments/2595/2595596-33c89694f65cfe28ff4dbbcac9ed5725.jpg

    HOW IS ANY OF THIS ALIGNING TO MAXIMISING SHAREHOLDER VALUE? WTF IS GOING ON HERE???

    I will be voting AGAINST Resolutions 1, 8 and 9.

    If anyone tells me they have managed to maintain the market cap or therabouts I will spew...its only via significant dilution that this was possible.

    Don't reward chronic underperformance. Perform and you will be rewarded adequately, not hard. Shareholders have the power to send this message to the Board. Don't be lazy and dismiss voting on this stuff, it matters.

 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.010(9.09%)
Mkt cap ! $126.0M
Open High Low Value Volume
11.0¢ 12.0¢ 11.0¢ $117.7K 1.017M

Buyers (Bids)

No. Vol. Price($)
3 341846 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 85200 2
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
11.5¢
  Change
0.010 ( 2.22 %)
Open High Low Volume
11.3¢ 12.0¢ 11.3¢ 346995
Last updated 15.35pm 16/05/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.